Obesity Management Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Diet, by Application, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Key Market Dynamics

The rising adoption of unhealthy eating habits among youth is contributing to an increase in instances of obesity. As a result, the prevalence of obesity is expected to support the growth of obesity management initiatives. This trend highlights the urgent need for effective strategies to address obesity, including lifestyle modifications, medical interventions, and public health campaigns. By tackling the prominent causes of unhealthy eating and promoting healthier choices, obesity management programs aim to mitigate the health risks associated with obesity and improve the overall well-being of the youth.
However, the growth of the medical services market faces hurdles due to limited trained personnel and a lack of awareness in developing economies regarding obesity management. In these regions, accessibility to quality healthcare services remains a challenge, intensifying the prevalence of obesity and its related health issues. Without adequate awareness campaigns and infrastructural improvements, the effective management of obesity becomes compromised. Consequently, the market's expansion is hindered, impacting both healthcare providers and individuals struggling with weight-related concerns in underserved areas.
Moreover, the escalating prevalence of obesity has spurred a growing demand for bariatric surgery, propelling significant growth in the obesity management market. This surgical intervention facilitates weight loss and is increasingly favored due to its effectiveness in managing severe obesity. As more individuals seek long-term solutions to weight management, the market for obesity interventions continues to expand rapidly. This trend highlights the critical need for comprehensive approaches to address the global obesity issue, with bariatric surgery emerging as a prominent solution in the healthcare landscape.

Analysis of Obesity Prevalence Globally

Obesity is a chronic, complex disease characterized by excessive fat deposits that can impair health, leading to an increased risk of type 2 diabetes, heart disease, bone health issues, reproductive problems, and certain cancers. It also affects the quality of life, impacting activities such as sleeping and moving. According to the WHO, in 2022, 2.5 billion adults aged 18 and older were overweight, including over 890 million adults living with obesity. This corresponds to 43% of adults aged 18 and over (43% of men and 44% of women) being overweight, a significant rise from 1990 when 25% of adults were overweight. The prevalence of overweight individuals varied by region, ranging from 31% in the WHO South-East Asia and African Regions to 67% in the Region of the Americas. Additionally, an estimated 37 million children under the age of 5 were overweight. Once considered a problem of high-income countries, overweight is increasingly seen in low- and middle-income countries. In Africa, the number of overweight children under 5 years has surged by nearly 23% since 2000, with almost half of the overweight or obese children under 5 in 2022 residing in Asia.

Global Obesity Prevalence, 2020–2035

Market Segmentation

The obesity management market is segmented into type, diet, application, end user, and region. On the basis of type, the market is divided into equipment, services, and supplements. As per diet, the market is segregated into meals, beverages, and nutraceuticals. Based on application, the market is segmented into body shaping, weight maintenance, aesthetic procedures, sports injuries, chronic wound management, and others. On the basis of end user, the market is divided into consulting services and commercial weight loss centers, fitness centers and health clubs, online weight loss programs, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
 

Regional Market Outlook

North America is expected to witness a notable surge in demand for obesity management solutions. This trend is supported by the increasing prevalence of obesity across the continent. With rising obesity rates among both adults and children, there is a surging need for effective management strategies. Factors such as sedentary lifestyles, unhealthy dietary habits, and a lack of access to nutritious foods contribute significantly to the obesity epidemic in North America. Consequently, individuals and healthcare professionals are increasingly recognizing the importance of proactive measures to address this issue. As a result, there is a growing demand for comprehensive obesity management programs that encompass dietary interventions, exercise regimens, behavioral therapy, and, in some cases, medical interventions.

In February 2024, CarelonRx unveiled a weight management initiative catering to individuals, including those on GLP-1 medications, interested in weight loss treatments. New England Journal of Medicine indicates, by 2030, half of U.S. adults would be affected with obesity, with a quarter facing severe obesity. A staggering 49% have attempted weight loss in the past year, while 45% express interest in prescription weight loss medication. The digital-first program offers access to digital coaching, wellness tools, and live human support, ensuring participants can monitor and manage weight goals effectively. Behavioral health and social health screenings further enrich personalized wellness plans, prioritizing holistic health approaches.

Competitive Landscape

The major players operating in the obesity management market include Eli Lilly and Company, Herbalife Ltd., Nutrisystem Ltd., Johnson Health Tech, The Kellogg Company, Nestle SA, Abbott Laboratories, Olympus Corporation, eDiets, Inc., and Brunswick Corporation. Other players in the obesity management market include Weight Watchers International, Inc., and Glanbia PLC.

Recent Key Strategies and Developments

In May 2024, Nestle expanded its brand portfolio with Vital Pursuit, a new line designed for GLP-1 weight loss medication users and those focused on weight management. Vital Pursuit’s meals would be high in protein, fiber, and essential nutrients, with gluten-free options and several air-fryer ready items. The frozen product range would include bowls with whole grains or protein pasta, sandwich melts, and pizzas, all portion-aligned for convenience. The suggested retail price for these meals will be $4.99 and under. This addition complements Nestle's existing brands like Life Cuisine, Lean Cuisine, and Boost.

Industry Trends

• In March 2024, Labcorp known for its innovative laboratory services, introduced its Weight Loss Management portfolio. This new offering includes educational resources and convenient testing solutions, empowering individuals and their physicians with critical baseline and ongoing health indicators to guide treatment options such as lifestyle changes, GLP-1 medications, or bariatric surgery. The Weight Management Baseline Test measures over 20 factors, including blood sugar, cholesterol, thyroid, and metabolic functions. These metrics are crucial for understanding health status before starting weight management efforts, as weight loss medications impact liver and kidney function, making baseline testing particularly important before initiating GLP-1 treatments.

• In November 2023, The FDA approved Eli Lilly's Zepbound (tirzepatide) injection, a unique obesity treatment activating both GIP and GLP-1 hormone receptors. Zepbound is intended for adults with a BMI of 30 kg/m² or higher, or those with a BMI of 27 kg/m² or higher who have weight-related conditions like hypertension, dyslipidemia, type 2 diabetes, sleep apnea, or cardiovascular disease. It should be used alongside a reduced-calorie diet and increased physical activity. Zepbound is not to be used with other tirzepatide products or GLP-1 receptor agonists and has not been studied in patients with pancreatitis or severe gastrointestinal diseases.

Key Sources Referred

1. The Obesity Society
2. World Obesity Federation
3. European Association for the Study of Obesity
4. Eli Lilly and Company
5. Nestle SA

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the obesity management market analysis from 2024 to 2033 to identify the prevailing obesity management market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the obesity management market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global obesity management market trends, key players, market segments, application areas, and market growth strategies.